1. Who is Spravato therapy at Waybridge right for?
Spravato therapy is FDA-approved specifically for adults experiencing:
- Treatment-resistant depression (TRD): Persistent depression despite trying at least two antidepressants.
- Major depressive disorder (MDD) with acute suicidal thoughts or behaviors.
If previous treatments haven't helped, Spravato therapy could provide a meaningful new direction for your mental health journey.
2. How does Spravato therapy at Waybridge work?
The treatment process at Waybridge includes:
- An initial comprehensive hour-long psychiatric consultation
- Personalized evaluation of your mental health history and prior treatment experiences
- Administration of Spravato nasal spray under careful medical supervision
- Post-treatment monitoring to ensure your comfort, safety, and wellbeing
3. How frequently will I need Spravato treatments?
Your provider will customize your treatment frequency based on clinical guidelines and your response:
- Induction phase: Typically twice weekly sessions for the first four weeks
- Maintenance phase: Usually once weekly or every other week, adjusted according to your response and clinical needs
Your provider will tailor the schedule to your individual needs.
4. What are the payment options for Spravato therapy?
Spravato therapy is typically covered by many insurance plans. Waybridge’s Care Coordinators assist you in verifying your insurance coverage, managing necessary authorizations, and simplifying the billing process to ensure a seamless experience.
